Clinsota
← Back to English Insights

Medical device regulatory insight · 2026-05-02

Clinsota invites you to attend the 3rd MDI Conference to explore “AI Agents Accelerating Global Market Access: Addressing the Core Challenges in Clinical Evaluation and Global Registration”

To accelerate innovation and resource integration in the medical device industry and deepen collaboration among industry, academia, research, and clinical practice, the “2026 MDI-China Medical Device Innovation & Collaboration Conference” (the 3rd MDI Conference), hosted by Yaozhi.com, will take pla

Clinsota invites you to attend the 3rd MDI Conference to explore “AI Agents Accelerating Global Market Access: Addressing the Core Challenges in Clinical Evaluation and Global Registration”
To accelerate innovation and resource integration in the medical device industry and promote deep collaboration across industry, academia, research, and healthcare, the“2026 MDI-China Medical Device Innovation & Collaboration Conference”(the 3rd MDI Conference) will take place onMay 8-9inWuxi.
On May 9, 13:40–14:10, Feng Huimei, founder of Shenzhen Clinsota, will deliver a featured presentation at the Medical Device Global Market Access Forum:

“AI Agents Unlock Faster Global Market Access: Solving the Core Challenges of Clinical Evaluation and Global Registration”

This presentation will focus on Clinsota’s independently developed vertical multi-agent AI platform for medical device clinical compliance and explain how it canthrough multi-agent role specialization, task orchestration, and structured data,enablethe automated execution of complex compliance tasks, while leveraging multi-agent collaboration and automated reasoning to deliver intelligent end-to-end clinical evaluation workflows. It will further examine how, with regulations as the foundation, clinical evaluation and registration activities can achieve standardized and consistent outputs, turning what was oncean uncertain process heavily dependent on individual experience into a reproducible and traceable path.

From "weeks or even months of manual work" to "core tasks completed within days"
From "compliance costs in the hundreds of thousands" to "a controllable five-figure level"
From "reliance on individual capability" to "overall performance at the level of a senior engineer"

With AI, medical device global expansion no longer relies on experience-driven improvisation, but on rule-based execution

We welcome industry colleagues to join us on site and turn uncertainty into certainty—together